United Therapeutics Reports Third-Quarter 2026 Results
Story updates
11:30:24 AM UTC
SquawkNews
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2026. Total revenues in the third quarter of 2026 increased by four percent year-over-year to $832.5 million, compared to $799.5 million in the thi…
11:30:35 AM UTC
SquawkNews
United Therapeutics 3Q EPS $5.71 >UTHR
11:30:37 AM UTC
SquawkNews
United Therapeutics 3Q Rev $832.5M >UTHR
11:37:33 AM UTC
SquawkNews
Beneficio neto de United Therapeutics cae un 24% a 258,6 millones de dólares en el tercer trimestre